1. |
17 Watabe T, Yoshida K, Shindoh M, et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
[ J ] . Int J Cancer, 1998; 77(1) ∶ 128.
|
2. |
Garcea G, Neal CP, Pattenden CJ, et al.Molecular prognostic markers in pancreatic cancer: a systematic review [J]. Eur J Cancer, 2005; 41(15)∶2213.
|
3. |
Kolb A, Kleeff J, Arnold N, et al. Expression and differential signaling of heregulins in pancreatic cancer cells [J]. Int J Cancer, 2007; 120(3)∶514.
|
4. |
董明, 周建平, 張浩, 等. 中國人與西方人胰腺癌組織中Ki-ras基因第12密碼子突變表型的比較[J]. 中國普外基礎與臨床雜志, 2006; 13(5)∶524.
|
5. |
Kayahara M, Nakagawara H, Kitagawa H, et al. The nature of neural invasion by pancreatic cancer [J]. Pancreas, 2007; 35(3)∶218.
|
6. |
Kleeff J, Beckhove P, Esposito I, et al. Pancreatic cancer microenvironment [J]. Int J Cancer, 2007; 121(4)∶699.
|
7. |
Tan X, Egami H, Nozawa F, et al. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells [J]. Int J Oncol, 2006; 28(2)∶369.
|
8. |
Tan X, Egami H, Ishikawa S, et al. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer [J]. Int J Oncol, 2005; 26(5)∶1283.
|
9. |
Pryczynicz A, Guzińska-Ustymowicz K, Dymicka-Piekarska V, et al. Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation [J]. Folia Histochem Cytobiol, 2007; 45(1)∶37.
|
10. |
Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells [J]. Cancer Res, 2006; 66(5)∶2778.
|
11. |
Takada M, Hirata K, Ajiki T, et al. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells [J]. Hepatogastroenterology, 2004; 51(58)∶928.
|
12. |
Harvey SR, Hurd TC, Markus G, et al. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer [J]. Clin Cancer Res, 2003; 9(13)∶4935.
|
13. |
Duxbury MS, Whang EE. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness [J]. Biochem Biophys Res Commun, 2007; 354(1)∶190.
|
14. |
張克君, 高焱明, 楊金鏞, 等. IκB-α基因轉染HCC9204細胞對NF-κB和MMP-9表達的影響[J]. 中國普外基礎與臨床雜志, 2006; 14(2)∶185.
|
15. |
Kajanne R, Miettinen P, Mehlem A, et al. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways [J]. J Cell Physiol, 2007; 212(2)∶489.
|
16. |
Shiratsuchi T, Ishibashi H, Shirasuna K. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines [J]. J Cell Physiol, 2002; 193(3)∶340.
|
17. |
Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells [J]. Mol Cancer Res, 2007; 5(5)∶413.
|